Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don W Cleveland

Showing results (61-70 of 248) with videos related to

Pageof 25
Sort By:
Annual Review of Neuroscience|July 9, 2019
Antisense Oligonucleotide Therapies for Neurodegenerative DiseasesC Frank Bennett, Adrian R Krainer, Don W Cleveland
Nature Clinical Practice. Neurology|August 26, 2006
Amyotrophic lateral sclerosis and gene therapyTimothy M Miller, Richard A Smith, Don W Cleveland
Cell|November 18, 2017
Rethinking Unconventional Translation in NeurodegenerationFen-Biao Gao, Joel D Richter, Don W Cleveland
The Journal of Cell Biology|March 4, 2009
Requirements for NuMA in maintenance and establishment of mammalian spindle polesAlain D Silk, Andrew J Holland, Don W Cleveland
Science (New York, N.Y.)|August 20, 2011
Cancer. Aneuploidy drives a mutator phenotype in cancerRichard D Kolodner, Don W Cleveland, Christopher D Putnam
Annual Review of Pharmacology and Toxicology|October 9, 2020
Antisense Drugs Make Sense for Neurological DiseasesC Frank Bennett, Holly B Kordasiewicz, Don W Cleveland
Bio-Protocol|November 8, 2016
Mitochondrial Isolation and Purification from Mouse Spinal CordPhilippe A Parone, Sandrine Da Cruz, Don W Cleveland
Annual Review of Neuroscience|June 26, 2004
Unraveling the mechanisms involved in motor neuron degeneration in ALSLucie I Bruijn, Timothy M Miller, Don W Cleveland
Nature|November 11, 2016
Decoding ALS: from genes to mechanismJ Paul Taylor, Robert H Brown, Don W Cleveland
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|September 16, 2008
Low rates of aneuploidy promote tumorigenesis while high rates of aneuploidy cause cell death and tumor suppressionBeth A A Weaver, Alain D Silk, Don W Cleveland
Pageof 25

Showing results (61-70 of 248) with videos related to

Sort By:
Pageof 25
Annual Review of Neuroscience|July 9, 2019
Antisense Oligonucleotide Therapies for Neurodegenerative DiseasesC Frank Bennett, Adrian R Krainer, Don W Cleveland
Nature Clinical Practice. Neurology|August 26, 2006
Amyotrophic lateral sclerosis and gene therapyTimothy M Miller, Richard A Smith, Don W Cleveland
Cell|November 18, 2017
Rethinking Unconventional Translation in NeurodegenerationFen-Biao Gao, Joel D Richter, Don W Cleveland
The Journal of Cell Biology|March 4, 2009
Requirements for NuMA in maintenance and establishment of mammalian spindle polesAlain D Silk, Andrew J Holland, Don W Cleveland
Science (New York, N.Y.)|August 20, 2011
Cancer. Aneuploidy drives a mutator phenotype in cancerRichard D Kolodner, Don W Cleveland, Christopher D Putnam
Annual Review of Pharmacology and Toxicology|October 9, 2020
Antisense Drugs Make Sense for Neurological DiseasesC Frank Bennett, Holly B Kordasiewicz, Don W Cleveland
Bio-Protocol|November 8, 2016
Mitochondrial Isolation and Purification from Mouse Spinal CordPhilippe A Parone, Sandrine Da Cruz, Don W Cleveland
Annual Review of Neuroscience|June 26, 2004
Unraveling the mechanisms involved in motor neuron degeneration in ALSLucie I Bruijn, Timothy M Miller, Don W Cleveland
Nature|November 11, 2016
Decoding ALS: from genes to mechanismJ Paul Taylor, Robert H Brown, Don W Cleveland
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|September 16, 2008
Low rates of aneuploidy promote tumorigenesis while high rates of aneuploidy cause cell death and tumor suppressionBeth A A Weaver, Alain D Silk, Don W Cleveland
Pageof 25